Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus lidocaine nebulization in elective endoscopic nasal surgery
PACTR202501722615802Phase 3Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, lidocaine and ketorolac in postoperative pain (3 arms), sponsored by Al-Azhar University. Primary endpoint: Postoperative pain by visual analog scale. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinelidocaineketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202501722615802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501722615802.